IPAM
Pharmaceuticals for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; diagnostic preparations for medical purposes for detecting presence of mutation in prion genes; medicines for human purposes for the treatment of cancer, epigenetic disease, neurodegenerative disease, genetic disorder, neuro...
Abandoned · March 29, 2022 · 97335375 ·